Purchases and Sales Made in Q3 2023 in Cyclacel Pharmaceuticals, Inc. (CYCC)
This table provides information about the institutional ownership of Cyclacel Pharmaceuticals, Inc. (CYCC) during Q3 2023. The information is specifically focused on institutions that hold shares of Cyclacel Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Kpp Advisory Services LLC
Louisville, KY |
BUY
|
- |
30.2KNew |
$8.45K - $22.6K
|
30.2K
$19K
|
|
|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
24.8K+ 40.17% |
$6.94K - $18.6K
|
86.4K
$54.4K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
19.2K+ 165.32% |
$5.36K - $14.4K
|
30.7K
$19.4K
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
14.8K+ 8.67% |
$4.14K - $11.1K
|
186K
$117K
|
|
|
Nov 15, 2023
Q3 2023
|
Mc Ilrath & Eck, LLC
|
BUY
|
- |
2.5K+ 25.0% |
$700 - $1.88K
|
12.5K
$7.88K
|
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
50New |
$14 - $37.5
|
50
$31.5
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 0.17% |
$0.28 - $0.75
|
580
$365
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-14- 0.39% |
$3.92 - $10.5
|
3.59K
$2.26K
|
|
|
Nov 14, 2023
Q3 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-1.59K- 8.8% |
$444 - $1.19K
|
16.4K
$10.3K
|
|
|
Nov 13, 2023
Q3 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-3.95K- 30.15% |
$1.11K - $2.96K
|
9.15K
$5.76K
|
|
|
Nov 14, 2023
Q3 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-636K- 95.73% |
$178K - $477K
|
28.4K
$17.9K
|